Literature DB >> 1324091

5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation.

M G Buzzi1, V Dimitriadou, T C Theoharides, M A Moskowitz.   

Abstract

Antidromic stimulation of small caliber trigeminal axons causes neurogenic inflammation in the dura mater and tongue as evidenced by marked increases in mast cell activation, protein extravasation, as well as in the numbers of endothelial cytoplasmic vesicles, endothelial microvilli and platelet aggregates within ipsilateral post-capillary venules. In this report, we examined the effects of pretreatment with serotonin1 receptor agonists, dihydroergotamine (50 micrograms/kg, i.v.) and sumatriptan (100 micrograms/kg, i.v.) on the light and electron microscopic changes which develop after trigeminal ganglion stimulation. Both dihydroergotamine and sumatriptan are useful in the acute treatment of vascular headaches and bind with high affinity to 5-HT1D receptors. Both drugs decreased significantly the number of dural vessels showing endothelial or platelet changes and the numbers of activated mast cells, but did not affect the neurogenic response in the tongue. The drugs also blocked the accumulation of horseradish peroxidase reaction product within the endothelium and perivascular space on the stimulated side. The receptor is not present on trigeminovascular fibers innervating extracranial cephalic tissues. Drug mechanism probably involves inhibition of a proximal step in the pathophysiological cascade (e.g., via activation of a prejunctional receptor) because (a) receptors for sumatriptan have not been identified on mast cells whereas the inflammatory response was attenuated in mast cells as well as within platelets and the endothelium and (b) previous work indicates that sumatriptan and dihydroergotamine block neurotransmitter release. Hence, constriction of vascular smooth muscle mediated by postjunctional 5-hydroxytryptamine receptors is unlikely to explain the anti-inflammatory actions of dihydroergotamine or sumatriptan reported here.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324091     DOI: 10.1016/s0006-8993(10)80017-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

Review 1.  [Neuropeptide effects on the trigeminal system: pathophysiology and clinical significance for migraine].

Authors:  K Messlinger; M J M Fischer; J K Lennerz
Journal:  Schmerz       Date:  2011-08       Impact factor: 1.107

2.  The non-peptide neurokinin1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats.

Authors:  S L Shepheard; D J Williamson; R G Hill; R J Hargreaves
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

3.  Pharmacology.

Authors:  Hayrunnisa Bolay; Paul Durham
Journal:  Handb Clin Neurol       Date:  2010

4.  Increase of capsaicin-induced trigeminal Fos-like immunoreactivity by 5-HT(7) receptors.

Authors:  Esther Martínez-García; Marcello Leopoldo; Enza Lacivita; José A Terrón
Journal:  Headache       Date:  2011 Nov-Dec       Impact factor: 5.887

5.  The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs.

Authors:  D J Williamson; R G Hill; S L Shepheard; R J Hargreaves
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

6.  Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development.

Authors:  G W Rebeck; K I Maynard; B T Hyman; M A Moskowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  Dural neurogenic inflammation induced by neuropathic pain is specific to cranial region.

Authors:  B Filipović; I Matak; Z Lacković
Journal:  J Neural Transm (Vienna)       Date:  2013-12-24       Impact factor: 3.575

8.  Mast cell degranulation activates a pain pathway underlying migraine headache.

Authors:  Dan Levy; Rami Burstein; Vanessa Kainz; Moshe Jakubowski; Andrew M Strassman
Journal:  Pain       Date:  2007-04-24       Impact factor: 6.961

9.  Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms.

Authors:  M A Moskowitz; K Nozaki; R P Kraig
Journal:  J Neurosci       Date:  1993-03       Impact factor: 6.167

10.  Time-dependent blockade of neurogenic plasma extravasation in dura mater by 5-HT1B/D agonists and endopeptidase 24.11.

Authors:  Z Huang; B Byun; T Matsubara; M A Moskowitz
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.